Cresco Labs (CRLBF) Capital Expenditures Growth (3y) (2023 - 2026)
Cresco Labs (CRLBF) Capital Expenditures Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.06 Bn | 20.90 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.62 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.81 Bn | 16.49 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 28.56% |
| 10 | Cresco Labs | 244.03 Mn | 180.46 Mn | 75.45 Mn | -87.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.72% |
| Dec 31, 2025 | -26.28% |
| Sep 30, 2025 | 29.64% |
| Jun 30, 2025 | 1.40% |
| Mar 31, 2025 | 45.32% |
| Dec 31, 2024 | -53.82% |
| Sep 30, 2024 | 38.30% |
| Jun 30, 2024 | 27.74% |
| Mar 31, 2024 | 26.80% |
| Dec 31, 2023 | -12.50% |
| Mar 31, 2023 | 26.79% |